Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics

December 22, 2021 updated by: University Hospital, Montpellier

The aim of this study is to correlate the intensity and the duration of a mechanical strain, applied over the skin of a bedridden paraplegics, with the microvascularization parameters (oxygen saturation, blood flow and blood volume) and the early inflammatory mechanism. We want to detect the early stage of irreversible damage for each patient. To achieve this goal, we measure some specifics data over a group of 48 paraplegics admitted in the hospital for a pressure ulcer surgical treatment. The patients are randomly distributed in 4 groups. First the interface pressure between the patient body and the air mattress is recorded continuously for 3 hours (= the repositioning patient frequency): we have the pressure over each point of the patient body in contact with the mattress on this time lap. Then, we will measure the microvascularization parameters, using an O2C medical device over a trochanter on a specific anatomical area which will be thereafter biopsied. Finally, depending on the group in which they were randomly distributed, the patient will undergo a muscle biopsy on his or her trochanter at 0h, 1h, 2h or 3h after they lie down on the air mattress. This way, we will be able to determine the effect of the mechanical strain duration on the physiologic parameters. The following day, the patient is undergoing his or her surgery for removing the necrotic area of the bedsore. At the same time, we will recover some of the sample near the bedsore which would serve as a maximum inflammatory response. Then a second muscle biopsy will be performed on an innervated area to be able to determine a basal concentration of biomarkers.

The inclusion period for this study will be 3 years. All the patients are followed for 24 hours then they will be followed by medical staff in their bedsore resection setting.

The data gained for this study will hopefully help the scientific world to achieve a better understanding of the pressure ulcer aetiology. They will also be helpful to achieve a mobilization of the patient specific of his or her inherent characteristics with a high sensitivity level. This way we will have a more efficient bedsore prevention.

Study Overview

Status

Terminated

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • CHU Montpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Educated consent signed,
  • Older than 18,
  • Paraplegia for at least 6 months,
  • Patient's Body Mass Index > 18,5kg/m²,
  • Surgery planned for pressure ulcer resection,
  • Pressure Ulcer classification (EPUAP) at least III or IV

Exclusion Criteria:

  • Cardiac pathology,
  • Duchenne muscular dystrophy,
  • Dementia,
  • Presence of a tumourous wound,
  • Stade IV arteritis non-revascularisable,
  • Diabetes mellitus,
  • Cachexia,
  • Impossibility to stop the anti-coagulant treatment 24 hours before the patient admission,
  • Xylocaine allergy,
  • Patient took aspirin or anti-inflammatory 3 days before the biopsy,
  • Patient taking part in another study,
  • Patient with no health insurance,
  • Pregnant women or breast-feeding, patient unable to give his or her educated consent, ward of the state (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Time of the first biopsy: H0
For the patients in arm H0, the first biopsy is done as soon as the patient is lying on the air mattress.
Active Comparator: Time of the first biopsy: H1
For a patient in arm H1, it is done after 1 hour lying on the air mattress.
Active Comparator: Time of the first biopsy: H2
For a patient in arm H2, it is done after 2 hour lying on the air mattress.
Active Comparator: Time of the first biopsy: H3
For a patient in arm H3, it is done after 3 hour lying on the air mattress.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The interface pressure will be continuously assessed using a mapping device (XSensor) during 3 hours.
Time Frame: The first day of the patient admission (during the first 3 hours).
The first day of the patient admission (during the first 3 hours).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The microvascularization changes underneath the compressed skin and the inflammatory response of the muscle cells.
Time Frame: The first day of the patient admission (during the first 3 hours).
The blood flow, the oxygen saturation and the hemoglobin amount will be measured using a medical device called Oxygen To See (O2C). The reactive oxygen species or ROS and other specific biomarkers will be used to measure and quantify the inflammatory response of muscle cells.
The first day of the patient admission (during the first 3 hours).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

October 2, 2019

Study Completion (Actual)

October 2, 2019

Study Registration Dates

First Submitted

April 3, 2015

First Submitted That Met QC Criteria

April 7, 2015

First Posted (Estimate)

April 8, 2015

Study Record Updates

Last Update Posted (Actual)

December 23, 2021

Last Update Submitted That Met QC Criteria

December 22, 2021

Last Verified

December 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injury

Clinical Trials on Muscle biopsy

Subscribe